Stepan Company (SCL)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $1.51B
Last updated: Nov 17, 2026 at 11:05 AM ET
Stepan Company (SCL) Earnings: Report Dates and Results
Stepan Company (SCL) is expected to report earnings on Feb 22, 2027. In the quarter ended Sep 30, 2026, Stepan Company reported EPS of $0.94, above the $0.73 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
SCL has an expected report date of Feb 22, 2027.
SCL Earnings Call
The latest SCL earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, SCL beat 23, missed 16 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $692.15M, up 17.3% from $590.28M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.94 | $0.73 | $0.60 - $0.85 | +28.77% | Beat | +95.8% | 2 | 0 up, 2 down | Oct 28, 2026 | $692.15M |
| Jun 30, 2026 | $1.18 | $0.61 | $0.58 - $0.64 | +93.44% | Beat | +126.9% | 2 | 0 up, 1 down | Jul 29, 2026 | $684.11M |
| Mar 31, 2026 | $0.45 | $0.39 | $0.21 - $0.56 | +15.38% | Beat | -46.4% | 2 | 0 up, 1 down | Apr 28, 2026 | $604.51M |
| Dec 31, 2025 | -$0.02 | $0.40 | $0.35 - $0.44 | -105.04% | Miss | -116.7% | 2 | 0 up, 1 down | Feb 23, 2026 | $553.89M |
| Sep 30, 2025 | $0.48 | $0.62 | $0.36 - $0.87 | -22.58% | Miss | -53.4% | 2 | 0 up, 0 down | Oct 29, 2025 | $590.28M |
| Jun 30, 2025 | $0.52 | $0.90 | $0.88 - $0.92 | -42.22% | Miss | +26.8% | 2 | 0 up, 0 down | Jul 30, 2025 | $594.69M |
| Mar 31, 2025 | $0.84 | $0.60 | $0.50 - $0.77 | +40.00% | Beat | +31.2% | 3 | 0 up, 1 down | Apr 29, 2025 | $593.25M |
| Dec 31, 2024 | $0.12 | $0.62 | N/A | -80.65% | Miss | -63.6% | 3 | 0 up, 3 down | Feb 19, 2025 | $525.61M |
| Sep 30, 2024 | $1.03 | $0.65 | $0.60 - $0.69 | +58.46% | Beat | +60.9% | 3 | 0 up, 1 down | Oct 30, 2024 | $546.84M |
| Jun 30, 2024 | $0.41 | $0.67 | $0.65 - $0.69 | -38.81% | Miss | -22.6% | 2 | 0 up, 0 down | Jul 31, 2024 | $556.40M |
| Mar 31, 2024 | $0.64 | $0.35 | $0.32 - $0.39 | +82.86% | Beat | -9.9% | 4 | 2 up, 0 down | Apr 30, 2024 | $551.42M |
| Dec 31, 2023 | $0.33 | $0.37 | $0.04 - $0.55 | -10.81% | Miss | -44.1% | 4 | 0 up, 0 down | Feb 20, 2024 | $532.13M |
| Sep 30, 2023 | $0.64 | $0.76 | $0.70 - $0.81 | -15.79% | Miss | -68.2% | 4 | 0 up, 2 down | Oct 18, 2023 | $562.23M |
| Jun 30, 2023 | $0.53 | $1.17 | $0.90 - $1.43 | -54.70% | Miss | -77.0% | 4 | 1 up, 1 down | Jul 26, 2023 | $579.98M |
| Mar 31, 2023 | $0.71 | $0.94 | $0.82 - $1.02 | -24.47% | Miss | -59.7% | 4 | 0 up, 0 down | Apr 25, 2023 | $651.44M |
| Dec 31, 2022 | $0.59 | $0.54 | $0.45 - $0.63 | +9.26% | Beat | -39.2% | 4 | 0 up, 0 down | Feb 16, 2023 | $627.18M |
| Sep 30, 2022 | $2.01 | $1.61 | $1.43 - $1.69 | +24.84% | Beat | +28.0% | 4 | 0 up, 0 down | Oct 19, 2022 | $719.18M |
| Jun 30, 2022 | $2.30 | $1.90 | $1.82 - $2.08 | +21.05% | Beat | +27.1% | 4 | 0 up, 0 down | Jul 27, 2022 | $751.63M |
| Mar 31, 2022 | $1.76 | $1.31 | $1.24 - $1.38 | +34.35% | Beat | +69.2% | 4 | 0 up, 0 down | Apr 26, 2022 | $675.28M |
| Dec 31, 2021 | $0.97 | $1.00 | $0.92 - $1.28 | -3.00% | Miss | -31.7% | 4 | 0 up, 0 down | Feb 17, 2022 | $610.03M |
| Sep 30, 2021 | $1.57 | $1.39 | $1.39 - $2.03 | +12.95% | Beat | +0.6% | 4 | 0 up, 0 down | Oct 20, 2021 | $602.69M |
| Jun 30, 2021 | $1.81 | $1.84 | $1.71 - $1.90 | -1.63% | Miss | +9.7% | 4 | N/A | Jul 28, 2021 | $595.51M |
| Mar 31, 2021 | $1.04 | $1.43 | $1.29 - $1.62 | -27.27% | Miss | 0.0% | 4 | N/A | Apr 27, 2021 | $537.74M |
| Dec 31, 2020 | $1.42 | $1.08 | $1.06 - $1.10 | +31.48% | Beat | +29.1% | 3 | N/A | Feb 18, 2021 | $494.73M |
| Sep 30, 2020 | $1.56 | $1.40 | $1.33 - $1.43 | +11.43% | Beat | +30.0% | 3 | N/A | Oct 21, 2020 | $464.48M |
| Jun 30, 2020 | $1.65 | $1.20 | $0.96 - $1.39 | +37.50% | Beat | +10.0% | 3 | N/A | Jul 22, 2020 | $460.55M |
| Mar 31, 2020 | $1.04 | $0.78 | $0.69 - $0.88 | +33.33% | Beat | -20.6% | 3 | N/A | Apr 21, 2020 | $449.99M |
| Dec 31, 2019 | $1.10 | $0.88 | $0.86 - $0.90 | +25.00% | Beat | +7.8% | 2 | N/A | Feb 20, 2020 | $444.99M |
| Sep 30, 2019 | $1.20 | $1.14 | $1.05 - $1.18 | +5.26% | Beat | +8.1% | 3 | N/A | Oct 23, 2019 | $451.58M |
| Jun 30, 2019 | $1.50 | $1.34 | $1.26 - $1.42 | +11.94% | Beat | +8.7% | 4 | N/A | Jul 24, 2019 | $473.00M |
| Mar 31, 2019 | $1.31 | $1.27 | $1.17 - $1.33 | +3.15% | Beat | -4.4% | 4 | N/A | Apr 30, 2019 | $489.17M |
| Dec 31, 2018 | $1.02 | $0.81 | $0.60 - $1.00 | +25.93% | Beat | -3.8% | 4 | N/A | Feb 21, 2019 | $466.66M |
| Sep 30, 2018 | $1.11 | $1.00 | $0.96 - $1.02 | +11.00% | Beat | +20.7% | 3 | N/A | Oct 24, 2018 | $508.00M |
| Jun 30, 2018 | $1.38 | $1.38 | $1.34 - $1.40 | 0.00% | In line | +4.5% | 3 | N/A | Jul 25, 2018 | $519.87M |
| Mar 31, 2018 | $1.37 | $1.46 | $1.46 - $1.47 | -6.16% | Miss | +0.7% | 3 | N/A | Apr 24, 2018 | $499.33M |
| Dec 31, 2017 | $1.06 | $0.72 | $0.63 - $0.82 | +47.22% | Beat | +103.8% | 3 | N/A | Feb 22, 2018 | $473.82M |
| Sep 30, 2017 | $0.92 | $1.09 | $1.03 - $1.14 | -15.60% | Miss | -13.2% | 3 | N/A | Oct 25, 2017 | $487.81M |
| Jun 30, 2017 | $1.32 | $1.34 | $1.32 - $1.36 | -1.49% | Miss | +0.8% | 3 | N/A | Jul 26, 2017 | $495.10M |
| Mar 31, 2017 | $1.36 | $1.19 | N/A | +14.29% | Beat | +5.4% | N/A | N/A | Apr 25, 2017 | $468.27M |
| Dec 31, 2016 | $0.52 | $0.69 | N/A | -24.64% | Miss | -29.7% | N/A | N/A | Feb 22, 2017 | $420.64M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $1.82, down 17.3% from the year before. It was $4.18 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $1.82 | -17.3% |
| Dec 31, 2024 | $2.20 | N/A |
| Dec 31, 2023 | $2.21 | -66.8% |
| Dec 31, 2022 | $6.66 | +23.6% |
| Dec 31, 2021 | $5.39 | -4.9% |
| Dec 31, 2020 | $5.67 | +11.0% |
| Dec 31, 2019 | $5.11 | +4.7% |
| Dec 31, 2018 | $4.88 | +4.7% |
| Dec 31, 2017 | $4.66 | +11.5% |
| Dec 31, 2016 | $4.18 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,300 words across 6 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 5,261 | 6 | |
| 2026Q2 | Jun 30, 2026 | 4,111 | 6 | |
| 2026Q1 | Mar 31, 2026 | 4,544 | 6 | |
| 2025Q4 | Dec 31, 2025 | 5,800 | 6 | |
| 2025Q3 | Sep 30, 2025 | 3,908 | 5 | |
| 2025Q2 | Jun 30, 2025 | 3,407 | 5 | |
| 2025Q1 | Mar 31, 2025 | 5,466 | 7 | |
| 2024Q4 | Dec 31, 2024 | 3,492 | 6 |
2026Q3 Earnings Call
Opening remarks
Ruben Velasquez CFO Thanks, Sherry. Good morning, and thank you for joining Stepan Company's third quarter 2026 financial review. Before we begin, please note that information in this conference call contains forward-looking statements, which are not historical facts. These statements involve risks and uncertainties that could cause actual results to differ materially, including, but not limited to, prospects for our foreign operations, global and regional economic conditions, and factors detailed in our Securities and Exchange Commission filings. In addition, this conference call will include discussions of adjusted net income, adjusted EBITDA, free cash flow, net debt, and leverage-related metrics, which are non-GAAP measures. We provide reconciliations to the comparable GAAP measures in the earnings presentation and press release, which we have made available at www.stepan.com under the investor section of our website. Whether you are joining us online or over the phone, we encourage you to review the investor slide presentation. We make these slides available at approximately the same time as when the earnings release is issued, and we hope that you find the information and perspectives helpful. With that, I would like to turn the call over to Mr. Luis E. Rojo, our president and chief executive officer.
Luis E. Rojo CEO Thank you, Ruben. Good morning, and thank you all for joining us today to discuss our third quarter 2026 results. I will share the highlights of the quarter and an update on our key strategic priorities, while Ruben will take you through the financial details. Before reviewing the quarter, I want to recognize our teams around the world for their commitment to safety. Safety remains our top priority and the foundation of everything we do at Stepan. Our safety performance over the last 12 months remained strong. The third quarter was another quarter of earnings growth for Stepan. The three segments delivered organic volume growth and increased earnings versus the prior year. Adjusted EBITDA was $66 million, up 18% versus the prior year, driven by global volume growth, margin recovery, and Project Catalyst savings. Surfactants adjusted EBITDA was up 27%. Polymers grew single digits, including one-time maintenance turnaround costs at our Germany site. Specialty Products grew EBITDA by single digits, driven by double-digit volume growth. On a consolidated basis, adjusted earnings per diluted share were $0.94, nearly twice the prior year. Now I want to highlight a few elements of our third quarter performance. First, volume growth. Organic volume grew 7%, with growth in all three segments. Surfactant organic volume was up 8%, and the growth was broad-based across most end markets. Polymers volume was up 3%, with North America growing strong double digits. Specialty Products delivered 20% volume growth, supported by a strong innovation plan in our MCT product line.
Frequently Asked Questions About SCL
When is Stepan Company's next earnings date?
Stepan Company's next earnings report is expected for Feb 22, 2027.
Did SCL beat earnings estimates last quarter?
Yes. Stepan Company reported EPS of $0.94 for the quarter ended Sep 30, 2026, above the $0.73 estimate, a 28.77% surprise.
What EPS do analysts expect from SCL next quarter?
The consensus EPS estimate for Stepan Company for the quarter ending Dec 31, 2026 is $0.34 from 3 analysts, with estimates from $0.29 to $0.40.
How often does SCL beat earnings estimates?
Stepan Company beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -9.11%.
SCL pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors